Postoperative Adjuvant Therapy Plays Different Roles for Esophageal Squamous Cell Carcinoma with Different Pathological Staging

1. Abstract
1.1. Background: Esophageal Squamous Cell Carcinoma (ESCC) causes a great disease burden in China and its prognosis remains poor. The role of adjuvant therapy in ESCC is controversial. The exploration of adjuvant therapy may benefit the maturation of the treatment strategy of ESCC.